Vigil Neuroscience Stock Performance
| VIGL Stock | USD 8.07 0.01 0.12% |
Vigil Neuroscience holds a performance score of 11 on a scale of zero to a hundred. The entity has a beta of 0.69, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vigil Neuroscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vigil Neuroscience is expected to be smaller as well. Use Vigil Neuroscience downside variance, and the relationship between the sortino ratio and accumulation distribution , to analyze future returns on Vigil Neuroscience.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vigil Neuroscience are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile technical and fundamental indicators, Vigil Neuroscience disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.12) | Five Day Return 0.12 | Year To Date Return 355.93 | Ten Year Return (36.21) | All Time Return (36.21) |
1 | VIGL Stock Alert Halper Sadeh LLC is Investigating Whether the Sale of Vigil Neuroscience, Inc. is Fair to Shareholders | 05/22/2025 |
2 | VIGL HC Wainwright Downgrades Vigil Neuroscience, Lowers Price Target VIGL Stock News | 05/27/2025 |
3 | Investment Analysts Weekly Ratings Changes for Vigil Neuroscience | 05/28/2025 |
4 | Should You Buy Vigil Neuroscience, Inc. After Golden Cross | 06/02/2025 |
5 | Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP | 06/04/2025 |
6 | Wall Street Analysts Think Vigil Neuroscience Could Surge 26.9 percent Read This Before Placing a Bet | 06/09/2025 |
7 | Wall Street Analysts See a 26.1 percent Upside in Vigil Neuroscience Can the Stock Really Move This High | 06/25/2025 |
8 | Acquisition by Booth Bruce of 9713 shares of Vigil Neuroscience at 3.03 subject to Rule 16b-3 | 06/27/2025 |
9 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders | 07/03/2025 |
| Begin Period Cash Flow | 52.9 M | |
| Total Cashflows From Investing Activities | 8.8 M |
Vigil Neuroscience Relative Risk vs. Return Landscape
If you would invest 180.00 in Vigil Neuroscience on April 22, 2025 and sell it today you would earn a total of 627.00 from holding Vigil Neuroscience or generate 348.33% return on investment over 90 days. Vigil Neuroscience is currently generating 4.4187% in daily expected returns and assumes 30.8529% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Vigil, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vigil Neuroscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vigil Neuroscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vigil Neuroscience, and traders can use it to determine the average amount a Vigil Neuroscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1432
| Best Portfolio | Best Equity | VIGL | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 30.85 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.42 actual daily | 89 89% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Vigil Neuroscience is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vigil Neuroscience by adding it to a well-diversified portfolio.
Vigil Neuroscience Fundamentals Growth
Vigil Stock prices reflect investors' perceptions of the future prospects and financial health of Vigil Neuroscience, and Vigil Neuroscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vigil Stock performance.
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.49 | ||||
| Current Valuation | 302.23 M | ||||
| Shares Outstanding | 46.67 M | ||||
| Price To Book | 5.78 X | ||||
| EBITDA | (83.8 M) | ||||
| Net Income | (84.26 M) | ||||
| Cash And Equivalents | 148.91 M | ||||
| Cash Per Share | 5.27 X | ||||
| Total Debt | 12.95 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 21.35 X | ||||
| Book Value Per Share | 1.40 X | ||||
| Cash Flow From Operations | (51.22 M) | ||||
| Earnings Per Share | (2.06) X | ||||
| Market Capitalization | 376.64 M | ||||
| Total Asset | 117.69 M | ||||
| Retained Earnings | (307.03 M) | ||||
| Working Capital | 66.44 M | ||||
About Vigil Neuroscience Performance
By examining Vigil Neuroscience's fundamental ratios, stakeholders can obtain critical insights into Vigil Neuroscience's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Vigil Neuroscience is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 3.4 K | 3.1 K | |
| Return On Tangible Assets | (0.72) | (0.75) | |
| Return On Capital Employed | (1.07) | (1.13) | |
| Return On Assets | (0.72) | (0.75) | |
| Return On Equity | (1.18) | (1.12) |
Things to note about Vigil Neuroscience performance evaluation
Checking the ongoing alerts about Vigil Neuroscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vigil Neuroscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vigil Neuroscience is way too risky over 90 days horizon | |
| Vigil Neuroscience appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (84.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vigil Neuroscience currently holds about 148.91 M in cash with (51.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.27. | |
| Vigil Neuroscience has a frail financial position based on the latest SEC disclosures | |
| Roughly 72.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from globenewswire.com: SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders |
- Analyzing Vigil Neuroscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vigil Neuroscience's stock is overvalued or undervalued compared to its peers.
- Examining Vigil Neuroscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vigil Neuroscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vigil Neuroscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vigil Neuroscience's stock. These opinions can provide insight into Vigil Neuroscience's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.